Hello Heart
Hello Heart is a digital therapeutics company that sells AI-powered cardiovascular health management—including FDA-cleared blood pressure monitors, the Nia AI assistant, and medication adherence tools—to large U.S. employers, health plans, public sector organizations, and labor unions on a value-based subscription model.
- Company typePrivate
- Founded2015
- HeadquartersMenlo Park, United States
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Hello Heart does
Hello Heart is a digital therapeutics company founded in 2013 and headquartered in Menlo Park, California, focused exclusively on cardiovascular disease management. The company's platform combines FDA-cleared connected blood pressure monitoring hardware with an AI-powered mobile application and a clinical evidence layer validated through peer-reviewed studies. Core products include the Hello Heart App (tracking blood pressure, cholesterol, weight, activity, and medications), the FDA-cleared Hello Heart Monitor, the Nia AI Heart Health Assistant, and the Hello Meds medication management suite including a connected pill box and pharmacist-led medication review service. The platform incorporates AI capabilities for risk detection, behavior change coaching, and personalized medication guidance, operating within clinician-defined guardrails.
The company serves large self-insured employers (500+ employees), Medicare Advantage/commercial health plans, public sector organizations, and labor unions/Taft-Hartley funds. Distribution combines a direct enterprise field-sales motion with embedded channel partnerships through CVS Health (Point Solutions Management program), Aetna, and Elevance/Anthem. Individual end users access the product free through employer or health plan benefits via self-service enrollment. The revenue model is a B2B value-based subscription in which 100% of fees are at-risk tied to clinical and financial outcomes, with a 1.5:1 ROI guarantee for new clients and pricing aligned to enrolled members achieving measurable outcomes.
Hello Heart has raised $138 million in total funding across multiple venture rounds, most recently a $70 million Series D led by Stripes in May 2022, and operates offices in Menlo Park, New York City, Austin, and Tel Aviv. The company reports 225+ employees, 452,000+ subscribers, and has been recognized on the Deloitte Technology Fast 500 (#184) and Inc. 5000 in 2025. Documented outcomes include 47% fewer inpatient hospital days, $1,709 annual savings per participant, 21 mmHg systolic blood pressure reduction over three years for high-risk members, and 42% reduced risk of cardiovascular events.
Hello Heart firmographics
Firmographics- Name
- Hello Heart
- Legal name
- Hello Heart, Inc.
- Website
- https://helloheart.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Hello Heart is a digital therapeutics company that sells AI-powered cardiovascular health management—including FDA-cleared blood pressure monitors, the Nia AI assistant, and medication adherence tools—to large U.S. employers, health plans, public sector organizations, and labor unions on a value-based subscription model.
- Ownership category
- akta.pro rank
Hello Heart industry classification
Industry- Product category
- Digital Health Therapeutics
- NAICS
- Social Assistance (624)
- SIC
- Services-Health Services (8000), Services-Home Health Care Services (8082)
- akta.pro primary industry
- Chronic Disease RPM Platforms (Diabetes/HTN/COPD/CHF) (HLACAFAA)
- akta.pro secondary industries
- AI/Analytics for RPM (Risk Stratification, Alerts, Predictive) (HLACAFAM), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG), Care Pathway Automation & Patient Engagement for RPM (Coaching, Messaging, Scheduling) (HLACAPAM), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)
Keywords
Where Hello Heart is headquartered
LocationHeadquarters
- HQ city
- Menlo Park
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Hello Heart business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain, Infrastructure
Revenue model
- Enterprise/B2B SaaS Subscription: Value-based pricing model where employers, health plans, and labor unions pay subscription fees for employee/member access to Hello Heart platform. 100% of fees are at-risk based on clinical and financial performance, demonstrating confidence in outcomes. Pricing tied to enrolled members who achieve meaningful outcomes.
- Individual Access (Employer/Health Plan Sponsored): Free to eligible individuals through employer-sponsored benefits or health plan coverage. Company receives revenue from enterprise clients rather than individual consumers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free blood pressure monitor and app for eligible individuals |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels9 records
Hello Heart product offering
Product offeringCore offering
Hello Heart provides an AI-powered cardiovascular digital therapeutics platform combining an FDA-cleared connected blood pressure monitor, a mobile app, and clinical expertise to help individuals monitor and improve heart health. The platform offers personalized coaching, medication management, AI-driven risk detection, and clinical reporting, and is distributed primarily through enterprise contracts with employers, health plans, public sector organizations, and labor unions on a value-based subscription model.
Product overview
Hello Heart is a digital therapeutics platform focused exclusively on cardiovascular health, combining a core mobile app with connected medical devices and AI-powered coaching modules. The product portfolio centers on the Hello Heart App as the primary interface, paired with the FDA-cleared Hello Heart Monitor for blood pressure tracking. AI capabilities are delivered through Nia, the 24/7 heart health assistant, while medication management is handled through Hello Meds, the Hello Heart Pill Box, and the Medication Review Service. The platform integrates these components to provide end-to-end heart health management including tracking, risk detection, personalized coaching, medication adherence, and clinical reporting for employers, health plans, and individuals.
Differentiator
Problem solved
Functional benefit
Brands
- Nia: AI Heart Health Assistant - a friendly AI assistant that provides medication and heart health guidance, anytime, integrated into the Hello Heart App
- Hello Meds
- Hello Heart Monitor
- Hello Heart Pill Box
Products and services
- Hello Heart App Comprehensive digital hub for managing heart health that tracks blood pressure, cholesterol, weight, activity, and medications; provides personalized coaching; sends reminders; and generates detailed clinical reports for clinicians. Made available to individuals through employer and health plan benefits.
- Hello Heart Monitor FDA-cleared blood pressure monitor offering simple one-touch operation with automatic syncing to the Hello Heart app, capturing clinically precise readings for blood pressure, heart rate, and irregular heartbeat detection in a lightweight, portable design.
- Nia: AI Heart Health Assistant 24/7 AI-powered heart health assistant integrated into the Hello Heart app that provides evidence-based guidance on prescriptions, side effects, drug interactions, and personalized insights based on each member's unique health journey.
- Hello Meds Medication management solution that combines an AI assistant, a connected pill box, and pharmacist-led reviews to help members take the right medications consistently and improve medication adherence for heart health.
- Hello Heart Pill Box Connected pill box with built-in light indicators that illuminate when it is time to take a dose, syncs directly with the Hello Heart app, has up to 14 compartments, supports a 2-week battery life from a single charge, and tracks medication adherence.
- Medication Review Service Pharmacist-led medication review service that identifies potential gaps in therapy, provides evidence-based recommendations to members and their doctors, and is delivered in-app with secure consent-based access and EHR integrations for comprehensive clinical reviews.
Quantifiable outcome
- 21 mmHg reduction in systolic blood pressure over 3 years for high-risk members (84% of participants reduced BP)
- +9 more outcomes
Companies that use Hello Heart
Customer profileNamed customers14 records
Segments5 records
Ideal customer profiles4 records
Hello Heart technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability8 records
Feature5 records
Hello Heart partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered flagship, core and minor.
- CVS HealthflagshipCVS Health Point Solutions Management program partner. CVS simplifies contracting for Hello Heart programs and enables broader distribution through CVS Caremark.
- Aetna (CVS Health subsidiary)flagshipChannel partner simplifying contracting for employer health benefits. Joint webinar on chronic condition gaps and cost containment.
- Elevance Health (Anthem)coreHealth plan partner enabling simplified contracting for employer and health plan clients.
- AoncoreIndependent analysis found $1,434 average reduction in medical costs per member per year. Aon study validates clinical and financial outcomes.
- SegalminorTaft-Hartley benefits consultancy. Segal study shows how one fund scaled digital heart health and reduced costs by $1,434 per member per year.
- UCSFcoreResearch partner. Peer-reviewed study co-authored with UCSF researchers published in JAMA Open Network demonstrating outcomes.
- Stanford UniversitycoreResearch partner. Stanford and Hello Heart demonstrated comparable improvements in blood pressure across several social determinants of health.
- American Heart AssociationcoreAHA Innovators' Network member. Collaboration on advancing cardiovascular health innovation and awareness.
- American College of CardiologycoreACC Industry Advisory Forum member. Strategic collaboration announced March 2026 to advance cardiovascular care.
- Johns Hopkins MedicinecoreMedical advisory board member Dr. Erin Michos, MD, MHS - Cardiologist and Director of Women's Cardiovascular Health at Johns Hopkins.
- Mayo CliniccoreMedical advisory board member Dr. Sharonne Hayes, MD - Vice Chair of Cardiovascular Medicine and Founder of Women's Heart Clinic at Mayo Clinic.
- Morehouse School of MedicinecoreResearch and advisory collaboration with Dr. Elizabeth Ofili, MD on cardiovascular health equity and women's heart health.
- Brigham and Women's HospitalcoreMedical advisory board member Dr. AJ Blood, MD - Cardiologist and Associate Director of Accelerator Clinical Transformation.
Scale indicators15 records
Recent moves6 records
Expansion highlights6 records
Hello Heart competitors and assessment
Company assessmentDirect peers
- Omada Health: Omada is a digital chronic care platform offering prevention and management programs for diabetes, hypertension, and behavioral health. It is the closest direct peer to Hello Heart given overlapping customer segments (employers, health plans, public sector), B2B2C value-based pricing, and chronic disease focus; differentiation is Hello Heart's cardiovascular-only specialization.
- Virta Health: Virta is a digital therapeutics company that reverses type 2 diabetes and other chronic metabolic conditions through nutrition and remote monitoring. It shares Hello Heart's enterprise channel, value-based contracting, and chronic-disease digital therapeutic model, but addresses cardiometabolic conditions via diabetes reversal rather than BP/cholesterol.
- DarioHealth: DarioHealth offers a multi-condition digital therapeutics platform for diabetes, hypertension, musculoskeletal, and behavioral health, sold to employers and health plans. It competes with Hello Heart on RPM and chronic disease management with a broader, multi-condition product set.
- WellDoc: WellDoc is a digital health company offering AI-driven chronic disease management, with a leading FDA-cleared platform for diabetes. It shares Hello Heart's RPM plus AI-driven coaching model and employer/health plan GTM, with a primary focus on diabetes rather than cardiovascular.
- Hinge Health: Hinge Health is a digital musculoskeletal therapeutics company that recently IPO'd, using connected sensors, AI coaching, and value-based pricing for employers and health plans. It shares Hello Heart's digital therapeutic, B2B2C, employer-channel model and recently brought in Hello Heart's new General Counsel from its IPO journey, signaling comparable scale and operating model.
Broad incumbents
- Livongo (Teladoc Health): Livongo pioneered the chronic-condition digital therapeutics category (initially diabetes, then hypertension) and was acquired by Teladoc. It pioneered the value-based, connected-device-plus-coaching model Hello Heart now operates in, and remains the broad incumbent benchmark for employer-channel digital chronic care.
- 1Life Healthcare (One Medical, Amazon): One Medical is a primary care membership platform acquired by Amazon that combines in-office care with a digital app for chronic and preventive care, including cardiovascular risk management. It represents a broader incumbent alternative for employers and health plans seeking integrated care delivery versus Hello Heart's specialty digital therapeutic.
Emerging players
- iRhythm Technologies: iRhythm is a digital health company that provides ambulatory cardiac monitoring (the Zio patch) with AI-based arrhythmia detection. It overlaps Hello Heart in cardiac focus and connected-device-plus-AI architecture, but is diagnostic/monitoring rather than chronic disease management.
- Eko Health: Eko builds AI-powered digital stethoscopes and cardiac monitoring devices with FDA-cleared algorithms for heart sound and ECG analysis. It shares Hello Heart's cardiac specialty and AI/connected-device approach, but is hardware-diagnostic rather than chronic care management.
- Withings: Withings is a connected health device maker offering smart blood pressure monitors, scales, and wearables integrated with health apps. It overlaps Hello Heart on the FDA-cleared connected BP monitor component and consumer/employer health ecosystems, but does not provide the full coaching or value-based service layer.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Hello Heart social profiles
Digital presenceHello Heart compliance and trust
Trust signalCompliance2 records
Hello Heart financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hello Heart leadership team
Management profileNumber of profiles
Profiles12 records
Hello Heart funding detail
Funding detailFunding overview
Funding rounds7 records
Investors16 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hello Heart M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hello Heart
What does Hello Heart do?
Hello Heart provides an AI-powered cardiovascular digital therapeutics platform combining an FDA-cleared connected blood pressure monitor, a mobile app, and clinical expertise to help individuals monitor and improve heart health. The platform offers personalized coaching, medication management, AI-driven risk detection, and clinical reporting, and is distributed primarily through enterprise contracts with employers, health plans, public sector organizations, and labor unions on a value-based subscription model.
Is Hello Heart a public or private company?
Hello Heart is a private company. It is classified as venture growth investor backed and is currently operating.
When was Hello Heart founded?
Hello Heart was founded in 2015. It employs 101 to 250 people.
Where is Hello Heart based?
Hello Heart is headquartered in Menlo Park, United States, in the North America region.
How does Hello Heart make money?
Two revenue lines are on record. Enterprise/B2B SaaS Subscription is the primary driver. The others are individual Access (Employer/Health Plan Sponsored).
Who are Hello Heart's main competitors?
Direct peers on record are Omada Health, Virta Health, DarioHealth, WellDoc and Hinge Health. Broad incumbents are Livongo (Teladoc Health) and 1Life Healthcare (One Medical, Amazon). Emerging players are iRhythm Technologies, Eko Health and Withings.
Does Hello Heart have an API?
No public API is recorded for Hello Heart.
What industry is Hello Heart in?
Hello Heart's product category is Digital Health Therapeutics. Its primary akta.pro industry code is HLACAFAA, Chronic Disease RPM Platforms (Diabetes/HTN/COPD/CHF), with a secondary code of HLACAFAM, AI/Analytics for RPM (Risk Stratification, Alerts, Predictive). Its NAICS code is 624 and its SIC code is 8000.